Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J




  • In Business
  • 2022-11-29 23:57:50Z
  • By Bloomberg
 

(Bloomberg) -- Horizon Therapeutics Plc soared in post-market US trading after the developer of medicines for rare autoimmune and inflammatory diseases said it's in talks with a trio of potential suitors about a possible sale of the company.

Most Read from Bloomberg

  • Scientists Revive 48,500-Year-Old 'Zombie Virus' Buried in Ice

  • Banks Stuck With $42 Billion Debt Seize Chance to Offload It

  • These Are the Best and Worst Cities for Expats to Live and Work In

  • This Is Where Luxury Property Prices May Rise and Fall the Most in 2023

  • Apple to Lose 6 Million iPhone Pros From Tumult at China Plant

Amgen Inc., Johnson & Johnson and Sanofi are separately engaged in preliminary discussions with Horizon, the company said in a statement on Tuesday. There's no certainty that any of the talks will lead to an offer. Dublin-based Horizon rose 30% in trading after markets closed in New York.

Emerging from the exhausting focus on Covid-19, big drugmakers are resuming their search for innovative therapies, especially for those that treat rare diseases and cancer. Merck & Co. earlier this year scuttled an estimated $37 billion bid for oncology drugmaker Seagen Inc., though it agreed this month to purchase Imago BioSciences Inc. to gain therapies for rare bone marrow conditions that lead to overproduction of blood cells.

Horizon had dropped 27% this year through Tuesday's close, valuing the company at $17.8 billion. The company gets almost half of its $3.6 billion in annual sales from Tepezza, a treatment for a painful autoimmune condition called thyroid eye disease. Other top drugs include Krystexxa for chronic gout and Ravicti, a treatment for inborn urea disorders.

Horizon is "a premier biotech company that offers significant growth opportunities across both commercialized and pipeline assets," Guggenheim Partners analysts led by Yatin Suneja said in a note. Based on sales estimates, they see a potential deal value of $25 billion to $30 billion.

Under Irish law, each company would have until 5 p.m. New York time on Jan. 10 to either step up with an offer or say it's backing out, Horizon said in the statement. The company has US operations in Deerfield, Illinois, and Rockville, Maryland.

(Updates with analysts' comment on potential deal value in penultimate paragraph.)

Most Read from Bloomberg Businessweek

  • Car Price Divergence Hints at More Painful Inflation Ahead

  • Tesla's Lithium Lead at Risk as Rivals Make Supply Deals

  • How to Keep Your Investments Halal

  • More Men Are Staying Out of the Workforce to Care for Kids

  • Apple's Reliance on China Grows Perilous With Chaos in iPhone City

©2022 Bloomberg L.P.

COMMENTS

More Related News

It Won
It Won't Take Much for the ECB to Crush Rate-Cut Bets Next Week

(Bloomberg) -- Most Read from BloombergAdani Rout Crosses $51 Billion as Stocks Plunge by Daily LimitsPutin Plans New Ukraine Push Despite Losses as He...

TikTok General Counsel No Longer Oversees US Relations
TikTok General Counsel No Longer Oversees US Relations

(Bloomberg) -- ByteDance Ltd.'s general counsel is no longer overseeing US government relations for TikTok, part of a shuffle to improve the company's...

China Kicks Off 2023 Leading Global Peers in Equity Fundraising
China Kicks Off 2023 Leading Global Peers in Equity Fundraising

(Bloomberg) -- Chinese firms are beating their US and European peers early in the year on equity financing, aided by optimism about the nation's reopening...

Tempers Flaring Over Onions Show Marcos Faces Risk on Prices
Tempers Flaring Over Onions Show Marcos Faces Risk on Prices

(Bloomberg) -- Ferdinand Marcos Jr made a curious move when he became Philippine president-elect in mid-2022: he named himself agriculture minister, pledging...

Goldman
Goldman's Dees Says Musk 2018 Go-Private Tweet Surprised Him

(Bloomberg) -- Dan Dees, one of Goldman Sachs Group Inc.'s most senior executives, told a jury he was surprised in August 2018 by Elon Musk's tweet about...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business